Vir Biotechnology Inc (VIR NASDAQ) stock market data APIs
$4.7909
0.02(0.4%)
as of September 17, 2025
Try our APIs with
free plan!
Vir Biotechnology Inc Financial Data Overview
Price chart is built with
Anychart
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Prev. Close
4.7909
Open
4.8122
High
5.0754
Low
4.7912
52 wk Range
4.155-14.45
Market Cap
675 M
Shares Outstanding
139 M
Revenue
19 000 K
EPS
-0.8
Beta
1.28
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Vir Biotechnology Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vir Biotechnology Inc data using free add-ons & libraries
Get Vir Biotechnology Inc Fundamental Data
Vir Biotechnology Inc Fundamental data includes:
- Net Revenue: 19 000 K
- EBITDA: -554 707 968
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-30
- EPS/Forecast: -0.7754
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vir Biotechnology Inc News
New
Stocks making the biggest moves midday: Alphabet, Bruker, Sprinklr, Dollar Tree & more
Check out the companies making the biggest moves midday: Bruker – The diagnostics solutions stock dropped more than 11% after it announce the sale of $600 million in convertible stocks. The decline ...
Stocks making the biggest moves premarket: Alphabet, Macy's, Dollar Tree, Six Flags and more
Check out the companies making headlines in premarket trading. Alphabet — The parent of Google and YouTube jumped more than 6% after a federal judge ruled that Alphabet can keep its Chrome browser. ...
Notable analyst calls this week: AMD, Eli Lilly and Constellation Brands among top picks
The S&P500 (SP500 [https://seekingalpha.com/symbol/SP500#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) closed in the red on Friday after the ...
Vir upgraded at BoA on potential for liver disease asset; shares surge 13%
[Liver damage such as Fatty liver, Fibrosis, Cirrhosis, and Liver cancer. 3d illustration] Mohammed Haneefa Nizamudeen BofA Securities has upgraded Vir Biotechnology (NASDAQ:VIR [https://seekingalpha...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
